Equities Research Analysts’ Price Target Changes for August, 9th (ACRS, BEAT, BLCM, CON, CORE, CRBP, DIS, ENDP, ESPR, EVHC)

Equities Research Analysts’ price target changes for Wednesday, August 9th:

Aclaris Therapeutics (NASDAQ:ACRS) was given a $50.00 price target by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.

BioTelemetry (NASDAQ:BEAT) had its target price raised by Dougherty & Co from $37.00 to $40.00. Dougherty & Co currently has a buy rating on the stock.

Bellicum Pharmaceuticals (NASDAQ:BLCM) was given a $18.00 price target by analysts at Raymond James Financial, Inc.. The firm currently has a buy rating on the stock.

Continental AG (ETR:CON) was given a €240.00 ($282.35) target price by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Core-Mark Holding (NASDAQ:CORE) was given a $35.00 price target by analysts at Raymond James Financial, Inc.. The firm currently has a buy rating on the stock.

Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) was given a $24.00 target price by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.

Walt Disney Company (The) (NYSE:DIS) was given a $133.00 target price by analysts at Goldman Sachs Group, Inc. (The). The firm currently has a buy rating on the stock.

Endo International PLC (NASDAQ:ENDP) was given a $13.00 price target by analysts at Deutsche Bank AG. The firm currently has a buy rating on the stock.

Esperion Therapeutics (NASDAQ:ESPR) was given a $64.00 target price by analysts at Deutsche Bank AG. The firm currently has a buy rating on the stock.

Envision Healthcare Corporation (NYSE:EVHC) had its target price cut by Mizuho from $65.00 to $57.00. The firm currently has a neutral rating on the stock.

Grammer AG (ETR:GMM) was given a €59.00 ($69.41) price target by analysts at Warburg Research. The firm currently has a buy rating on the stock.

Hertz Global Holdings (NYSE:HTZ) was given a $14.00 price target by analysts at Deutsche Bank AG. The firm currently has a hold rating on the stock.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) was given a $175.00 target price by analysts at Deutsche Bank AG. The firm currently has a buy rating on the stock.

Lumentum Holdings (NASDAQ:LITE) had its target price boosted by UBS AG from $66.00 to $70.00.

Mallinckrodt PLC (NYSE:MNK) was given a $56.00 price target by analysts at Deutsche Bank AG. The firm currently has a buy rating on the stock.

Myriad Genetics (NASDAQ:MYGN) had its target price lowered by Barclays PLC from $28.00 to $26.00. The firm currently has an equal weight rating on the stock.

Mylan N.V. (NASDAQ:MYL) was given a $34.00 price target by analysts at Cantor Fitzgerald. The firm currently has a hold rating on the stock.

Plains All American Pipeline, L.P. (NYSE:PAA) was given a $24.00 price target by analysts at Raymond James Financial, Inc.. The firm currently has a buy rating on the stock.

Plains Group Holdings, L.P. (NYSE:PAGP) was given a $24.00 target price by analysts at Raymond James Financial, Inc.. The firm currently has a buy rating on the stock.

Paylocity Holding Corporation (NASDAQ:PCTY) was given a $55.00 target price by analysts at Raymond James Financial, Inc.. The firm currently has a buy rating on the stock.

Progenics Pharmaceuticals (NASDAQ:PGNX) was given a $15.00 price target by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock. The analysts wrote, “NDA Submission for Azedra this Month. PGNX has completed a pre- submission meeting for Azedra with the FDA and an NDA submission should follow this month. The drug has been awarded Breakthrough designation and was developed under a SPA. Top line results were released earlier this year and a fuller data set is expected to be presented at the International Symposium of Pheochromocytoma and Paraganglioma on September 1.””

Red Robin Gourmet Burgers (NASDAQ:RRGB) was given a $75.00 price target by analysts at Raymond James Financial, Inc.. The firm currently has a buy rating on the stock.

Southern Copper Corporation (NYSE:SCCO) had its price target raised by Barclays PLC from $33.00 to $35.00. Barclays PLC currently has an underweight rating on the stock.

Volkswagen AG (ETR:VOW3) was given a €175.00 ($205.88) price target by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Get Analysts’ Upgrades and Downgrades Daily – Enter your email address below to receive a concise daily summary of analysts’ upgrades, downgrades and new coverage with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

15 − 2 =